IP Verse

Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof

Patent No. EP2695609 (titled "Oral Formulations Of Cytidine Analogs And Methods Of Use Thereof") was filed by Celgene on May 14, 2009. The application was issued on Dec 11, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANDOZSep 11, 2020TER MEER STEINMEISTER & PARTNER GBR
HOFFMANN EITLESep 10, 2020HOFFMANN EITLE
TEVA PHARMACEUTICAL INDUSTRIES LTDSep 4, 2020D YOUNG
GENERICS UKAug 30, 2020ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2695609

CELGENE
Application Number
EP13182721A
Filing Date
May 14, 2009
Status
Revoked
Jul 4, 2025
Publication Date
Dec 11, 2019
External Links
Slate, Register , Google Patents